Health Care & Life Sciences » Biotechnology | Cara Therapeutics Inc.

Cara Therapeutics Inc.

Cara Therapeutics Inc.
Stock Exchange Frankfurt Stock Exchange
EPS
-
Market Cap
-
Shares Outstanding
39.29 M
Public Float
27.93 M
Cara Therapeutics Inc.
Stock Exchange NASDAQ Stock Market
EPS
$2.11
Market Cap
$866.99 M
Shares Outstanding
39.75 M
Public Float
34.8 M

Profile

Address
4 Stamford Plaza
Stamford Connecticut 06902
United States
Employees -
Website http://www.caratherapeutics.com
Updated 07/08/2019
CARA Therapeutics, Inc. engages in the research, development, and commercialization of pharmaceutical products. Its portfolio includes opioid-based products, anesthetic-based drugs, and analgesics that targets to alleviate itch and pain. The company was founded by Derek T.

Financials

View All

Derek T. Chalmers
President, Chief Executive Officer & Director
Chris Posner
Director